Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-21 | Mr. Charles S. HyleInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 16,02k | 11,64% |
| 2026-04-22 | Ms. Laura L. WhitleyIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 9,63k | 20,98% |
| 2026-04-22 | Mr. Dale W. TremblayIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 18,00k | 10,23% |
| 2026-04-22 | Mr. Robert William StallingsInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 294,96k | 0,57% |
| 2026-04-22 | Mr. Steven P. RosenbergIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 42,38k | 4,10% |
| 2026-04-22 | Mr. Mark W. MidkiffIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 2,80k | 147,27% |
| 2026-04-22 | Ms. Elysia Holt RagusaInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 18,80k | 9,75% |
| 2026-04-22 | Mr. Thomas E. LongIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 12,17k | 15,90% |
| 2026-04-22 | Mr. David S. HuntleyLead Independent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 12,47k | 15,47% |
| 2026-04-22 | Ms. Ranjana Bhattacharya ClarkIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,67k | - |
| 2026-04-22 | Mr. Jonathan E. BaliffIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 11,27k | 17,40% |
| 2026-04-22 | Ms. Paola M. ArbourIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 8,34k | 25,03% |
| 2026-03-11 | Ms. Paola M. ArbourIndependent Director | 1.000,00 | 91,50k | Kauf | 91,50 | 6,67k | 17,63% |
| 2026-03-05 | Mr. Robert William StallingsInsider | 25,50k | 579,20k | Kauf | 22,69 - 22,80 | - | - |
| 2026-03-03 | Mr. Robert William StallingsInsider | 45,00k | 1,00M | Kauf | 22,11 - 22,51 | - | - |
| 2026-02-27 | Mr. Robert William StallingsInsider | 3,33k | 315,88k | Kauf | 94,86 | 293,29k | 1,15% |
| 2026-02-27 | Mr. Robert William StallingsInsider | 20,00k | 444,40k | Kauf | 22,22 | - | - |
| 2026-02-27 | SCG Ventures LPUnternehmen | 5,00k | 111,45k | Kauf | 22,29 | - | - |
| 2026-02-23 | SCG Ventures LPUnternehmen | 40,00k | 888,00k | Kauf | 22,14 - 22,26 | - | - |
| 2026-02-20 | Mr. Robert C. HolmesChairman, President & CEO | -1,45k | 141,17k | Derivative Exercise and Sale | 97,63 | 266,24k | - |
| 2026-02-17 | SCG Ventures LPUnternehmen | 10,00k | 221,28k | Kauf | 22,11 - 22,20 | - | - |
| 2026-02-13 | Mr. Robert C. HolmesChairman, President & CEO | 6,03k | 0,00 | Derivative Exercise and Retained Stock | - | 266,24k | 2,32% |
| 2026-02-13 | Mr. Robert C. HolmesChairman, President & CEO | -3,54k | 366,11k | Derivative Exercise and Sale | 103,42 | 266,24k | - |
| 2026-02-13 | Mr. John Matthew ScurlockMD & CFO | 1,10k | 0,00 | Derivative Exercise and Retained Stock | - | 22,24k | 5,22% |
| 2026-02-13 | Mr. John Matthew ScurlockMD & CFO | -716,00 | 74,05k | Derivative Exercise and Sale | 103,42 | 22,24k | - |
| 2026-02-13 | Mr. John W. CummingsMD & COO | 891,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,13k | 7,28% |
| 2026-02-13 | Mr. John W. CummingsMD & COO | -579,00 | 59,88k | Derivative Exercise and Sale | 103,42 | 13,13k | - |
| 2026-02-13 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 773,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,31k | 2,91% |
| 2026-02-13 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -503,00 | 52,02k | Derivative Exercise and Sale | 103,42 | 27,31k | - |
| 2026-02-09 | Ellen E. DetrichController & CAO | 983,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,57k | 11,44% |
| 2026-02-09 | Ellen E. DetrichController & CAO | -390,00 | 40,80k | Derivative Exercise and Sale | 104,62 | 9,57k | - |
| 2026-02-09 | Mr. Robert C. HolmesChairman, President & CEO | 18,16k | 0,00 | Derivative Exercise and Retained Stock | - | 260,21k | 7,50% |
| 2026-02-09 | Mr. Robert C. HolmesChairman, President & CEO | -11,45k | 1,20M | Derivative Exercise and Sale | 104,62 | 260,21k | - |
| 2026-02-09 | Mr. John W. CummingsMD & COO | 3,36k | 0,00 | Derivative Exercise and Retained Stock | - | 12,24k | 37,86% |
| 2026-02-09 | Mr. John W. CummingsMD & COO | -1,08k | 113,20k | Derivative Exercise and Sale | 104,62 | 12,24k | - |
| 2026-02-09 | Mr. John Matthew ScurlockMD & CFO | 2,82k | 0,00 | Derivative Exercise and Retained Stock | - | 21,13k | 15,41% |
| 2026-02-09 | Mr. John Matthew ScurlockMD & CFO | -1,83k | 191,66k | Derivative Exercise and Sale | 104,62 | 21,13k | - |
| 2026-02-09 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 2,33k | 0,00 | Derivative Exercise and Retained Stock | - | 26,54k | 9,63% |
| 2026-02-09 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -1,53k | 159,96k | Derivative Exercise and Sale | 104,62 | 26,54k | - |
| 2026-02-04 | SCG Ventures LPUnternehmen | 16,89k | 360,58k | Kauf | 21,35 - 21,36 | - | - |
| 2026-02-02 | SCG Ventures LPUnternehmen | 4,12k | 86,76k | Kauf | 20,97 - 21,10 | - | - |
| 2026-01-29 | SCG Ventures LPUnternehmen | 7,00k | 146,45k | Kauf | 20,91 - 20,94 | - | - |
| 2026-01-29 | Mr. John W. CummingsMD & COO | 1,06k | 0,00 | Derivative Exercise and Retained Stock | - | 8,88k | 13,51% |
| 2026-01-29 | Mr. John W. CummingsMD & COO | -442,00 | 43,70k | Derivative Exercise and Sale | 98,87 | 8,88k | - |
| 2026-01-29 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 652,00 | 0,00 | Derivative Exercise and Retained Stock | - | 24,21k | 2,77% |
| 2026-01-29 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -526,00 | 52,01k | Derivative Exercise and Sale | 98,87 | 24,21k | - |
| 2026-01-29 | Mr. David W. OmanMD & Chief Risk Officer | 722,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,39k | 43,34% |
| 2026-01-29 | Mr. David W. OmanMD & Chief Risk Officer | -584,00 | 57,74k | Derivative Exercise and Sale | 98,87 | 2,39k | - |
| 2026-01-29 | Mr. John Matthew ScurlockMD & CFO | 1,55k | 0,00 | Derivative Exercise and Retained Stock | - | 16,94k | 10,09% |
| 2026-01-29 | Mr. John Matthew ScurlockMD & CFO | -1,12k | 111,13k | Derivative Exercise and Sale | 98,87 | 16,94k | - |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | 9,20k | 0,00 | Derivative Exercise and Retained Stock | - | 242,05k | 3,95% |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | -881,00 | 86,01k | Derivative Exercise and Sale | 97,63 | 242,05k | - |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | -3,40k | 336,55k | Sale to Issuer | 98,87 | 242,05k | -1,39% |
| 2026-01-23 | Ms. Laura L. WhitleyIndependent Director | 1.000,00 | 97,54k | Kauf | 97,51 - 97,56 | 7,96k | 14,37% |
| 2026-01-23 | SCG Ventures LPUnternehmen | 2,00k | 41,82k | Kauf | 20,91 | - | - |
| 2025-11-05 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 3,14k | 0,00 | Derivative Exercise and Retained Stock | - | 23,56k | 15,35% |
| 2025-11-05 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -2,04k | 173,42k | Derivative Exercise and Sale | 85,22 | 23,56k | - |
| 2025-10-28 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -177,00 | 0,00 | Other Disposition | - | 20,42k | -0,86% |
| 2025-10-28 | SCG Ventures LPUnternehmen | 5,00k | 104,15k | Kauf | 20,83 | - | - |
| 2025-10-24 | SCG Ventures LPUnternehmen | 15,00k | 309,50k | Kauf | 20,61 - 20,68 | - | - |
| 2025-07-01 | Mr. David W. OmanMD & Chief Risk Officer | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,67k | - |
| 2025-07-01 | Mr. David W. OmanMD & Chief Risk Officer | -1,08k | 89,29k | Derivative Exercise and Sale | 82,60 | 1,67k | - |
| 2025-06-11 | Stallings FoundationUnternehmen | 10,50k | 212,94k | Kauf | 20,28 | - | - |
| 2025-06-02 | SCG Ventures LPUnternehmen | 7,00k | 138,46k | Kauf | 19,78 | - | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
